(2R,3S,4R,5R,6R)-5-氨基-2-(氨基甲基)-6-(((1R,2R,3S,4R,6S)-4,6-二氨基-2,3-二羟基环己基)氧基)四氢-2H-吡喃-3,4-二醇

Neamine

产品编号.: A947657 CAS号: 3947-65-7
分子式: C12H26N4O6 分子量: 322.35804
纯度: 95% MDL NO.:

中文名称:(2R,3S,4R,5R,6R)-5-氨基-2-(氨基甲基)-6-(((1R,2R,3S,4R,6S)-4,6-二氨基-2,3-二羟基环己基)氧基)四氢-2H-吡喃-3,4-二醇
CAS号:3947-65-7
中文别名:新霉胺;新霉素 EP标准品;新霉素A;新霉素A(新霉胺);新黴素A
英文名称:Neamine
英文别名:D-Streptamine,2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-;(1'R,3'S,3S,5R,6R)-5-AMINO-2-AMINOMETHYL-6-(4,6-DIAMINO-2,3-DIHYDROXY-CYCLOHEXYLOXY)-TETRAHYDRO-PYRAN-3,4-DIOL;Neamine;NEAMINE, EP STANDARD;2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-D-streptamine;dekamycinv;neamin;nebramycinx;Negamicin;neomycina;U-5214;(2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol;NS00011537;3947-65-7;4-18-00-07474 (Beilstein Handbook Reference);(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}oxane-3,4-diol;NEOMYCIN SULFATE IMPURITY A [EP IMPURITY];4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine;CS-0129171;TOBRAMYCIN IMPURITY C [EP IMPURITY];BRN 0026714;D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-;D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl)-;O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-1,3-DIAMINO-1,2,3-TRIDEOXY-D-MYO-INOSITOL;Neomycin A;Nebramycin X;A824565;NEAMINE [MI];HY-N7449;SYJXFKPQNSDJLI-HKEUSBCWSA-N;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxyoxane-3,4-diol;Q6984256;(2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol Hydrochloride;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyloxy)tetrahydro-2H-pyran-3,4-diol;SCHEMBL219578;AKOS025311197;2-Desoxy-4-O-(2,6-diamino-2,6-didesoxy-alpha-D-glucopyranosyl)-D-streptamin;(2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-3,4-DIOL;Dekamycin V;C01441;(1R,3S,3S,5R,6R)-5-Amino-2-aminomethyl-6-(4,6-diamino-2,3-dihydroxy-cyclohexyloxy)-tetrahydro-pyran-3,4-diol;DTXSID7023358;CHEBI:7489;ST 7;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxy-cyclohexoxy]tetrahydropyran-3,4-diol;Neamine Disulfate Salt;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-tetrahydro-2H-pyran-3,4-diol;UNII-5981U00LY0;(+)-NEAMINE;DB04808;2-Deoxy-4-O-(2,6-diamine-2,6-dideoxy-.alpha.-D-glucopyranosyl)-D-streptamine;5981U00LY0;XXX;CHEMBL427409;(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside;BDBM8580;MFCD00023857;2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine Disulfate Salt; Neomycin A Disulfate Salt
EINECS:215-766-3
分子式:C12H26N4O6
分子量:322.35804
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

(2R,3S,4R,5R,6R)-5-氨基-2-(氨基甲基)-6-(((1R,2R,3S,4R,6S)-4,6-二氨基-2,3-二羟基环己基)氧基)四氢-2H-吡喃-3,4-二醇
D-Streptamine,2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-;(1'R,3'S,3S,5R,6R)-5-AMINO-2-AMINOMETHYL-6-(4,6-DIAMINO-2,3-DIHYDROXY-CYCLOHEXYLOXY)-TETRAHYDRO-PYRAN-3,4-DIOL;Neamine;NEAMINE, EP STANDARD;2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-D-streptamine;dekamycinv;neamin;nebramycinx;Negamicin;neomycina;U-5214;(2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol;NS00011537;3947-65-7;4-18-00-07474 (Beilstein Handbook Reference);(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}oxane-3,4-diol;NEOMYCIN SULFATE IMPURITY A [EP IMPURITY];4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine;CS-0129171;TOBRAMYCIN IMPURITY C [EP IMPURITY];BRN 0026714;D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-;D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl)-;O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-1,3-DIAMINO-1,2,3-TRIDEOXY-D-MYO-INOSITOL;Neomycin A;Nebramycin X;A824565;NEAMINE [MI];HY-N7449;SYJXFKPQNSDJLI-HKEUSBCWSA-N;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxyoxane-3,4-diol;Q6984256;(2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol Hydrochloride;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyloxy)tetrahydro-2H-pyran-3,4-diol;SCHEMBL219578;AKOS025311197;2-Desoxy-4-O-(2,6-diamino-2,6-didesoxy-alpha-D-glucopyranosyl)-D-streptamin;(2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-3,4-DIOL;Dekamycin V;C01441;(1R,3S,3S,5R,6R)-5-Amino-2-aminomethyl-6-(4,6-diamino-2,3-dihydroxy-cyclohexyloxy)-tetrahydro-pyran-3,4-diol;DTXSID7023358;CHEBI:7489;ST 7;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxy-cyclohexoxy]tetrahydropyran-3,4-diol;Neamine Disulfate Salt;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-tetrahydro-2H-pyran-3,4-diol;UNII-5981U00LY0;(+)-NEAMINE;DB04808;2-Deoxy-4-O-(2,6-diamine-2,6-dideoxy-.alpha.-D-glucopyranosyl)-D-streptamine;5981U00LY0;XXX;CHEMBL427409;(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside;BDBM8580;MFCD00023857;2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine Disulfate Salt; Neomycin A Disulfate Salt